ImmunityBio stock rose 19.8% after FDA meeting on ANKTIVA bladder cancer treatment. Company to submit additional data within ...
ANKTIVA is an Interleukin-15 (IL-15) receptor agonist that helps develop and activate key cells that work to destroy cancer ...
ImmunityBio Inc. (NASDAQ:IBRX) shares climbed nearly 20% in premarket trading on Tuesday after the company said it held positive discussions with the U.S. Food and Drug Administration regarding its ...
MedPage Today on MSN
Color Blindness and Bladder Cancer: A Bad Combination for Survival?
A retrospective cohort study suggested that people with color blindness may have a higher risk of mortality from bladder ...
Urinary retention is a serious medical condition that affects millions of people worldwide and can lead to significant ...
After suffering in silence, these women are relying on a pessary and the results have been life-changing. What to know about ...
People who are colorblind may be missing a life-saving warning sign of bladder cancer. Analysis of the electronic health ...
Published, peer-reviewed research shows a patent-pending, virus-mimicking platform technology developed at Purdue University ...
A man who was left with a bladder the size of a 'shot glass' has issued a warning after a ketamine addiction left him needing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback